These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17703230)

  • 1. Minimizing leakage of value from R&D alliances.
    Jones A
    Nat Rev Drug Discov; 2007 Sep; 6(9):711-9. PubMed ID: 17703230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug discovery alliances.
    Jones A; Clifford L
    Nat Rev Drug Discov; 2005 Oct; 4(10):807-8. PubMed ID: 16237845
    [No Abstract]   [Full Text] [Related]  

  • 3. The state of innovation in drug development.
    Kola I
    Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deals landscape: notable deals in the pharmaceutical industry in the first quarter of 2008.
    Shumoogam J; Al-Shamahi A
    IDrugs; 2008 May; 11(5):351-5. PubMed ID: 18465677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's fueling the biotech engine?
    Aggarwal S
    Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug Discovery and Development Asia-Pacific Conference 2005. Strategies and case studies of successful alliances, licensing and outsourcing partnerships.
    Alger L
    IDrugs; 2005 Aug; 8(8):639-41. PubMed ID: 16044371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. R&D investments for neglected diseases can be sensitive to the economic goal of pharmaceutical companies.
    Dimitri N
    Drug Discov Today; 2012 Aug; 17(15-16):818-23. PubMed ID: 22414544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoting drug discovery by collaborative innovation: a novel risk- and reward-sharing partnership between the German Cancer Research Center and Bayer HealthCare.
    Wellenreuther R; Keppler D; Mumberg D; Ziegelbauer K; Lessl M
    Drug Discov Today; 2012 Nov; 17(21-22):1242-8. PubMed ID: 22521665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic development: a victim of market forces?
    Tillotson GS
    IDrugs; 2008 May; 11(5):340-6. PubMed ID: 18465675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GAO report says drug R & D costs rising, innovation decreasing.
    Consult Pharm; 2007 Mar; 22(3):257-8. PubMed ID: 17691159
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathways across the valley of death: novel intellectual property strategies for accelerated drug discovery.
    Rai AK; Reichman JH; Uhlir PF; Crossman C
    Yale J Health Policy Law Ethics; 2008; 8(1):1-36. PubMed ID: 18564492
    [No Abstract]   [Full Text] [Related]  

  • 12. Partnerships in Pharma--An Economist Intelligence Unit Seminar--Building Innovation into Alliances and Business Models. 1 October 2010, London, UK.
    Kibble A
    IDrugs; 2010 Dec; 13(12):813-5. PubMed ID: 21154130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple rules for making alliances work.
    Hughes J; Weiss J
    Harv Bus Rev; 2007 Nov; 85(11):122-6, 128, 130-1 passim. PubMed ID: 18159792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When to ally & when to acquire.
    Dyer JH; Kale P; Singh H
    Harv Bus Rev; 2004; 82(7-8):108-15, 188. PubMed ID: 15241957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What should be done to improve the productivity of neurological research?
    Moses H; Martin JB
    Ann Neurol; 2006 Dec; 60(6):647-51. PubMed ID: 17192925
    [No Abstract]   [Full Text] [Related]  

  • 16. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NIH, research institutions and industry: working together on a shared goal.
    Omary MB
    Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
    [No Abstract]   [Full Text] [Related]  

  • 18. Recruiters and industry.
    Jackson M
    Nature; 2004 Mar; 428(6981):450. PubMed ID: 15042100
    [No Abstract]   [Full Text] [Related]  

  • 19. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
    Federsel HJ
    Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universities should foster neglected-disease work.
    Chokshi DA
    Nature; 2005 May; 435(7039):143. PubMed ID: 15889064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.